|
|
 |
|
Viewing report
|
|
|
|
Acorda Therapeutics, Inc. - SWOT Analysis
MarketLine, Oct 2011, Pages: 28
Acorda Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Acorda Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Acorda Therapeutics (Acorda) is a commercial-stage biotechnology company engaged in the development and marketing of therapies to restore function in persons with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the central nervous system (CNS). Acorda's marketed products include Ampyra (dalfampridine), Zanaflex Capsules (tizanidine hydrochloride) and Zanaflex (tizanidine hydrochloride) tablets. The company primarily operates in the US. It is headquartered in Hawthorne, New York, and employed 305 people as of February 17, 2011. The company recorded total net revenues of $191 million during the financial year (FY) ended December 2010, as compared to the revenues of $54.7 million in FY2009. The operating loss of the company was $8.4 million during FY2010, as compared to an operating loss of $81.3 million in FY2009. The net loss was $11.8 million in FY2010, as compared to a net loss of $83.9 million in FY2009.
Scope of the Report
- Provides all the crucial information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Acorda Therapeutics, Inc.
-Data is supplemented with details on Acorda Therapeutics, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Acorda Therapeutics, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
